Data / Form D filings / Odyssey Therapeutics, Inc.
Odyssey Therapeutics, Inc.: Form D filings
Odyssey Therapeutics, Inc., a biotechnology company in Boston, MA, filed 5 Form D notices with the SEC between 2021 and 2025. The latest, on December 4, 2025, reports $214 million sold of a $214 million offering to 55 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 51 SLEEPER STREET, Boston, MA, 02210
- Phone
- (617) 865-9628
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1882782
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | New notice | $214,025,200 | $214,025,200 | 55 | Jun 16, 2025 | sec.gov | |
| Aug 14, 2024 | Amendment | $121,080,000 | $117,210,000 | $3,870,000 | 43 | Oct 25, 2023 | sec.gov |
| Dec 15, 2023 | New notice | $106,000,000 | $97,130,000 | $8,870,000 | 39 | Oct 25, 2023 | sec.gov |
| Oct 27, 2022 | New notice | $174,909,939 | $168,009,933 | $6,900,006 | 34 | May 13, 2022 | sec.gov |
| Oct 14, 2021 | New notice | Indefinite | $91,629,837 | 63 | Aug 30, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Valerie D. Odegard | Director | |
| Carl D. Gordon | Director | |
| Carolyn F. Ng | Director | |
| Gary D. Glick | Executive Officer, Director | |
| Timothy D. Walbert | Director | |
| Paulina D. Hill | Director | |
| Nan D. Li | Director | |
| Jeffrey D. Leiden | Director | |
| Jason F. Haas | Executive Officer | |
| Nia F. Tatsis | Director | |
| Ksenija F. Pavletic | Director | |
| Shelley F. Chu | Director | |
| lan F. Smith | Director | |
| Jill D. Carroll | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 1, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Odyssey Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.